<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HR0382</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HR0382 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0382</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 13732 ECR 26454 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><center><code>HOUSE RESOLUTION</code></center><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Batten disease is a progressive and devastating </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>neurodegenerative childhood disease, with symptoms including </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>developmental delays, dementia, cognitive decline, vision </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>loss, seizures, and loss of motor skills, ultimately resulting </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>in premature death; and</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Batten disease is a rare genetic disease wherein </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>most of those affected inherit a recessive gene from each </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>asymptomatic parent; the disease inhibits the production of </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>essential levels of cellular enzymes, leading to the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>accumulation of metabolic waste in brain cells, causing the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>cells to lose function over time and die; and</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, At least 14 different variants of Batten disease </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>have been identified, and these variants are most often </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>referred to as CLN1 through CLN14; and</code><br> </td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Due to its rarity, sufferers of Batten disease </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>often experience significant delays in being properly </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>diagnosed, with an accurate diagnosis sometimes taking years; </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>and</code><br> </td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Only a single variant of Batten disease, CLN2, </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>currently has an FDA-approved therapeutic option, which is an </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0382</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 13732 ECR 26454 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>enzyme replacement therapy intended to delay disease </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>progression; currently, numerous variants of the disease have </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>genetic-based therapies either in development or are being </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>administered to patients on an experimental basis; and</code><br> </td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The burdens of rare childhood diseases, and </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Batten disease in particular, are significant, requiring </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>extensive utilization of medical, financial, caretaking, and </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>emotional resources on affected patients, their families, and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>their communities; and</code><br> </td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Due to many rare diseases being progressive, </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>including Batten disease, early diagnosis provides the best </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>chance of a successful treatment or therapy; and</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Illinois is home to Rush University Medical </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>Center, an institution recognized as one of only nine Batten </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>Disease Centers of Excellence in the United States; and</code><br> </td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Dr. Elizabeth Berry-Kravis, a pediatric </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>neurologist and professor of Pediatrics, Neurological </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Sciences, and Biochemistry at Rush University Medical Center, </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>is also the clinic director of the Rush University Medical </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>Center Batten Disease Center, where she works tirelessly on </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>cutting-edge medicine and science to advance novel genetic </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>treatments for children afflicted with rare diseases, </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0382</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 13732 ECR 26454 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>including Batten disease; and</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Charlie Sims, an energetic and loving </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>eight-year-old boy from Naperville, was diagnosed with Batten </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>disease at age six and is living with the CLN1 variant; and</code><br> </td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Charlie Sims has undergone first-in-the-world </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>experimental genetic treatments for his CLN1 Batten disease at </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>Rush University Medical Center, under the supervision and care </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>of Dr. Elizabeth Berry-Kravis, in an attempt to slow the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>progression of his disease and to establish valuable research </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>data so that other children in the future may also receive </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>novel and life-extending genetic therapies for Batten disease; </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>and</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Following his diagnosis, Charlie Sims' family and </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>friends created Team Charlie in 2023, establishing an </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>organization committed to bringing awareness of Batten disease </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>and other rare pediatric diseases to the public, engaging in </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>philanthropy for the benefit of Batten disease and all rare </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>disease families, and assisting in the advancement of novel </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>genetic treatments for all children afflicted by rare </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>pediatric diseases, including Batten disease; therefore, be it</code><br> </td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0382</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 13732 ECR 26454 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>we declare June 9, 2025 as Batten Disease Awareness Day in the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>State of Illinois in order to recognize and bring awareness to </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>the rare disease population, including those living with </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>Batten disease in Illinois, and to recognize the heroic and </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>tireless efforts of Dr. Elizabeth Berry-Kravis and her </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>esteemed colleagues at Rush University Medical Center as they </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>attempt to save children afflicted with Batten disease by </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>searching for treatments and a cure; and be it further</code><br> </td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>RESOLVED, That we commend Charlie Sims for advancing the </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>scientific development of treatments for Batten disease for </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>children everywhere, his family and friends for valiantly </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>facing the difficulties of Batten disease, and the ongoing </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>efforts of Team Charlie in their continued work of finding </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>hope, giving love, and being good.</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
